Halotherapy and Pulmonary Fibrosis

Pulmonary fibrosis is a chronic lung disease characterized by the formation of scar tissue within the lungs. It is a relatively rare condition. In pulmonary fibrosis, the oxygen uptake is impaired due to the development of fibrous tissue, also known as scarring. Fibrosis literally means scarring. The formation and increase of scar tissue often result from an inflammatory process. In pulmonary fibrosis, excessive connective tissue is formed during inflammation. As a consequence, the lungs function less effectively because they cannot adequately absorb oxygen. There are many different forms of pulmonary fibrosis. Sometimes, when the cause of pulmonary fibrosis is unknown, it is referred to as idiopathic pulmonary fibrosis (IPF).

Some symptoms associated with pulmonary fibrosis include shortness of breath, easy fatigue, and low energy levels. Several causes of pulmonary fibrosis include exposure to harmful substances, rheumatic diseases, and the use of certain medications. The manifestation of the disease in the body can vary greatly from person to person. Unfortunately, damaged lung tissue cannot regenerate.